Moleculin Biotech
MBRX
MBRX
23 hedge funds and large institutions have $131K invested in Moleculin Biotech in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 0 reducing their positions, and 4 closing their positions.
Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
8
Reduced
–
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citigroup
New York
|
$25.7K |
| 2 |
XT
2
XTX Topco
George Town,
Cayman Islands
|
$22.4K |
| 3 |
VF
3
Virtu Financial
New York
|
$18K |
| 4 |
VCP
4
Verus Capital Partners
Scottsdale,
Arizona
|
$13K |
| 5 |
5
LPL Financial
San Diego,
California
|
$16.9K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Fidelity Investments
Boston,
Massachusetts
| – | – | -34 | Closed |
|
27
Royal Bank of Canada
Toronto,
Ontario, Canada
| $0 | 1 | – | – |
|